Add Tribune As Your Trusted Source
TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My Money
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill ViewBenchmark
Don't Miss
Advertisement

Feluda paper strip test to be out in few weeks

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

New Delhi, October 11

Advertisement

Health Minister Harsh Vardhan today said the indigenously developed Feluda paper strip test for SARS-CoV-2 diagnosis could be rolled out over the next few weeks.

Advertisement

“While I cannot put an exact date on the availability, we should expect this test within the next few weeks,” he said during an online interaction. Named after the renowned detective created by Satyajit Ray, the test was developed by Tata CRISPR and the Council of Scientific and Industrial Research’s Institute of Genomics and Integrative Biology.

Also read: Chandigarh, Maharashtra use less than 50% of COViD-19 grant: Harsh Vardhan

Advertisement

Vardhan said the exposure risk and co-morbidities would determine the prioritisation of groups for administration of Covid vaccine, dispelling apprehensions that youngsters and working class people would get preference in inoculation for economic reasons.

He said one vaccine would not suffice India’s needs and the government was open to introducing several vaccines. He said emergency-use authorisation of vaccines was still being debated and adequate safety and efficacy data was required before a decision could be taken. — TNS

Advertisement
Show comments
Advertisement